These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA, Gadad AK. J Med Chem; 2006 Jan 26; 49(2):475-89. PubMed ID: 16420035 [Abstract] [Full Text] [Related]
6. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results. Opera TI, Waller CL, Marshall GR. Drug Des Discov; 1994 Jul 26; 12(1):29-51. PubMed ID: 7578806 [Abstract] [Full Text] [Related]
8. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA). Xing L, Welsh WJ, Tong W, Perkins R, Sheehan DM. SAR QSAR Environ Res; 1999 Jul 26; 10(2-3):215-37. PubMed ID: 10491851 [Abstract] [Full Text] [Related]
9. Halogen bonding in ligand-receptor systems in the framework of classical force fields. Rendine S, Pieraccini S, Forni A, Sironi M. Phys Chem Chem Phys; 2011 Nov 21; 13(43):19508-16. PubMed ID: 21964576 [Abstract] [Full Text] [Related]
10. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor. Zhang H, Li H, Ma Q. J Mol Graph Model; 2007 Jul 21; 26(1):226-35. PubMed ID: 17208024 [Abstract] [Full Text] [Related]
11. AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X. Ibrahim MA. J Phys Chem B; 2012 Mar 22; 116(11):3659-69. PubMed ID: 22393912 [Abstract] [Full Text] [Related]
12. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T, Zhu L, Chen L, Xu X. J Chem Inf Comput Sci; 2003 Mar 22; 43(1):273-87. PubMed ID: 12546563 [Abstract] [Full Text] [Related]
15. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G, Saxena AK. J Chem Inf Model; 2006 Apr 15; 46(6):2579-90. PubMed ID: 17125198 [Abstract] [Full Text] [Related]
16. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. Lu Y, Wang Y, Zhu W. Phys Chem Chem Phys; 2010 May 14; 12(18):4543-51. PubMed ID: 20428531 [Abstract] [Full Text] [Related]
17. Role of halogen bonds in thyroid hormone receptor selectivity: pharmacophore-based 3D-QSSR studies. Valadares NF, Salum LB, Polikarpov I, Andricopulo AD, Garratt RC. J Chem Inf Model; 2009 Nov 14; 49(11):2606-16. PubMed ID: 19863110 [Abstract] [Full Text] [Related]
18. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses. Guo Y, Xiao J, Guo Z, Chu F, Cheng Y, Wu S. Bioorg Med Chem; 2005 Sep 15; 13(18):5424-34. PubMed ID: 15963726 [Abstract] [Full Text] [Related]
19. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models. Puntambekar DS, Giridhar R, Yadav MR. Eur J Med Chem; 2008 Jan 15; 43(1):142-54. PubMed ID: 17448576 [Abstract] [Full Text] [Related]
20. Grid-based Continual Analysis of Molecular Interior for Drug Discovery, QSAR and QSPR. Potemkin AV, Grishina MA, Potemkin VA. Curr Drug Discov Technol; 2017 Jan 15; 14(3):181-205. PubMed ID: 28176631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]